Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mittermaier, C.
Right arrow Articles by Moser, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mittermaier, C.
Right arrow Articles by Moser, G.

Impact of Depressive Mood on Relapse in Patients With Inflammatory Bowel Disease: A Prospective 18-Month Follow-Up Study

Christian Mittermaier, MD*, Clemens Dejaco, MD*, Thomas Waldhoer, PhD, Anna Oefferlbauer-Ernst, MD, Wolfgang Miehsler, MD, Markus Beier, MD, Wolfgang Tillinger, MD, Alfred Gangl, MD and Gabriele Moser, MD

From the Department of Medicine IV, Division of Gastroenterology and Hepatology (C.D., A.O. W.M., M.B., W.T., A.G., G.M.), Department of Physical Medicine and Rehabilitation (C.M.), and Department of Epidemiology, Institute of Tumor Biology (T.W.), University Hospital of Vienna, Vienna, Austria.



View larger version (13K):

[in a new window]
  		Fig. 1. BDI scores remained stable during the 18 months of follow-up. Patients with IBD were divided into depressed (BDI >=13) and nondepressed subjects (BDI <13) at baseline.

 


View larger version (14K):

[in a new window]
  		Fig. 2. Patients with depression (BDI >=13) were at risk for an earlier relapse than nondepressed subjects (BDI <13); *p <.05. Arrows indicate median time to first relapse.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Psychosomatic Society